Management of Atrial Fibrillation Post Transcatheter Aortic Valve Implantation

Atrial fibrillation (AF) is a common complication in patients who underwent transcatheter aortic valve implantation. Some of these patients have preexisting AF as well. The manage-ment of these patients is complex, especially after the procedure, when there is a sudden change in hemodynamics. There are no established guidelines about the management of the patients who underwent transcatheter aortic valve replacement with preexisting or new-onset AF. This review article discusses the management of these patients with rate and rhythm control strategies with medications. This article also highlights the role of newer oral anticoagulation medications and left atrial occlusion devices to prevent stroke after the procedure. We will also discuss new advances in the care of this patient popula-tion to prevent the occurrence of AF after transcatheter aortic valve implantation. In con-clusion, this article is a synopsis of both pharmacologic and device interventions for the management of AF in patients who underwent transcatheter aortic valve replacement. & COPY; 2023 Elsevier Inc. All rights reserved. (Am J Cardiol 2023;200:171-177)